ECL
57
-2
A
41
-3
PVH
62
2
MAR
65
2
NDAQ
56
4
FFIV
70
3
CTSH
56
4
EL
37
-3
ESS
59
2
EFX
46
2
MRK
25
-5
INTU
62
5
URBN
70
-2
TSN
32
-3
HCA
44
-2
KMB
30
-3
MOS
50
4
T
45
-2
PM
50
-4
GD
39
-2
ECL
57
-2
A
41
-3
PVH
62
2
MAR
65
2
NDAQ
56
4
FFIV
70
3
CTSH
56
4
EL
37
-3
ESS
59
2
EFX
46
2
MRK
25
-5
INTU
62
5
URBN
70
-2
TSN
32
-3
HCA
44
-2
KMB
30
-3
MOS
50
4
T
45
-2
PM
50
-4
GD
39
-2
Financhill
Back

Franklin Income Equity Focus ETF Vs. Aligos Therapeutics Industry Stock Comparison

Buy
52

INCE
Franklin Income Equity Focus ETF

Last Price:
57.43
Seasonality Move:
1.46%
Buy
75

ALGS
Aligos Therapeutics

Last Price:
34.48
Seasonality Move:
10.65%
Buy
52
Franklin Income Equity Focus ETF (INCE) is a Buy

Is Franklin Income Equity Focus ETF a Buy, Sell or Hold?

  • The current Franklin Income Equity Focus ETF [INCE] share price is $57.45. The Score for INCE is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • INCE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

INCE Stock Price Chart

What is Franklin Income Equity Focus ETF's stock price today?

  • The Franklin Income Equity Focus ETF share price today is $57.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INCE is experiencing selling pressure, which indicates risk of future bearish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $34.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

INCE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 35.97 Sell
Chaikin Money Flow: -1693 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.88 - 58.86) Sell
Bollinger Bands (100): (56.01 - 58.73) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.71 Buy
Relative Strength Index (14 RSI): 85.17 Buy
Chaikin Money Flow: 491004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 27.66) Buy
Bollinger Bands (100): (7.67 - 19.61) Buy

INCE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.99 Sell
20-day SMA: 58.34 Sell
50-day SMA: 58.38 Sell
200-day SMA: 55.51 Buy
8-day EMA: 57.94 Sell
20-day EMA: 58.21 Sell
50-day EMA: 58.07 Sell
200-day EMA: 55.68 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.48 Buy
20-day SMA: 23.64 Buy
50-day SMA: 14.76 Buy
200-day SMA: 15.86 Buy
8-day EMA: 28.77 Buy
20-day EMA: 23.99 Buy
50-day EMA: 18.16 Buy
200-day EMA: 16.13 Buy

Franklin Income Equity Focus ETF Earnings Growth & INCE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Franklin Income Equity Focus ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):